Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tipelukast by MediciNova for Type 2 Diabetes: Likelihood of Approval
Tipelukast is under clinical development by MediciNova and currently in Phase II for Type 2 Diabetes. According to GlobalData, Phase...